Edwards Lifesciences Corp (NYSE:EW)
$ 88.93 -1.18 (-1.31%) Market Cap: 53.59 Bil Enterprise Value: 53.30 Bil PE Ratio: 38.33 PB Ratio: 7.52 GF Score: 98/100

Edwards Lifesciences Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 03:50PM GMT
Release Date Price: $89.37 (-1.43%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Welcome, everyone. I'm Robbie Marcus, the medtech analyst at JPMorgan. I'm very happy to host for our next session Edwards Lifesciences. We're going to start off with the presentation by Mike Mussallem, the CEO. We're going to follow up with Q&A. And Scott Ullem, the CFO, is going to join us there.

For those of you who this is your first session, go to the JPMorgan healthcare conference web book, and you can find the slides available for download. And Mike will be calling out slide numbers. You can follow along. There's also an ask a question feature. So feel free to submit a question. It goes directly just to me, and I can ask it for you in the Q&A session. And then feel free to always e-mail me or Bloomberg, chat me, and I can ask your questions for you.

So with that, Mike, I'm going to turn it over to you, and I will follow up with Q&A afterwards.

Michael A. Mussallem
Edwards Lifesciences Corporation - Chairman & CEO

All right. Well, thank you,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot